Welcome : Guest

Takeda Pharmaceutical Company Ltd. (Japan) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Takeda Pharmaceutical Company Ltd., which is principally involved in the Manufacture and Distribution of Pharmaceuticals. Illustrated with 100 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00127
Price: $3500
Company Type: Public
Pages: 108
Date: October 2015
Market Data Tables: 100

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Takeda Pharmaceutical Co., Ltd.’s Sales by Business Segment Worldwide (2013-2014) in Percentage for Ethical Drugs, Consumer Healthcare and Others......6
Table 2: Takeda Pharmaceutical Co., Ltd.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Japan, United States, Europe, Asia and Others......7
Pharmaceuticals......8
Table 3: Pharmaceuticals Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......8
Table 4: Pharmaceuticals Sales by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......9
Table 5: Pharmaceuticals Market by Region in European Union (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Great Britain, Italy, Spain, and Others......10
Table 6: Pharmaceutical Drugs Market by Category in Germany (2014) – Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......11
Table 7: Pharmaceuticals by Therapeutic Area in China (2014) - Percentage Market Share Breakdown by Value Sales for Alimentary & Metabolism, Anti-Infective, Cardiovascular, Central Nervous System, Neoplasm, and Others......12
Table 8: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2014) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......13
Table 9: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......14
Table 10: Research & Development Spending in Pharmaceuticals by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......15
Table 11: Speciality Pharmaceuticals Market by Category in the US (2014) – Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......16
Table 12: Pharmaceutical Market by Category in Canada (2015)-Percentage Share Breakdown by Value for Hospital and Retail......17
Table 13: Pharmaceutical Market by Category in Vietnam (2015)-Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......18
Table 14: Pharmaceutical Market by Country in Europe (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......19
Table 15: Pharmaceutical Market by Country Worldwide (2015)-Percentage Share Breakdown by Value for China, Japan, USA and Others......20
Table 16: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......21
Table 17: Pharmaceutical Market by Region in Latin America (2015)-Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......22
Table 18: Pharmaceutical Prescription Segment Market by Category in Indonesia (2015)-Percentage Share Breakdown by Value for Unbranded Generic and Other Prescription......23
Table 19: Pharmaceuticals Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......24
Table 20: Pharmaceuticals Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify, AdvairDiskus, Crestor, Cymbalta, Enbrel, Humira, Nexium, Remicade, and Others......25
Table 21: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......26
Table 22: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Nervous System, Oncology and Immunomodulating Agents, Systemic Anti-infectives, Musculo-Skeletal System and Others......27
Table 23: Pharmaceuticals Prescription Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Amlodipine, Hydrocodone/Acetaminophen, Levothyroxine, Lisinopril, Metformin, Metoprolol, Omeprazole, Salbutamol, Simvastatin, and Others......28
Prescription Drugs......29
Table 24: Prescription Drugs Market in the US (2014) in US$ Million......29
e-Prescriptions......30
Table 25: e-Prescription Adoption by Chain Pharmacies in US (2010-2014) (in Thousands)......30
Table 26: e-Prescription Adoption Rates by Small Practitioners in the US (%) - 2014......31
Table 27: e-Prescription Adoption Rates by Specialization in the US (%) - 2014......32
Table 28: US States Ranked by Safe e-Prescription Adoption Rates - 2014......33
Table 29: Number of e-Prescriptions (2010-2014) Routing in Million......34
Antibiotics......35
Table 30: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......35
Table 31: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......36
Cardiovascular Drugs......37
Table 32: Cardiovascular Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......37
CNS Drugs......38
Table 33: Central Nervous System (CNS) Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......38
Table 34: Central Nervous System Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......39
Cancer Drugs......40
Table 35: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......40
Table 36: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......41
Table 37: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......42
Table 38: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......43
Table 39: Cancer Market by Type in China (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......44
Table 40: Cancer-Associated Mucositis Market by Activity Worldwide (2015)-Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......45
Table 41: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......46
Table 42: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......47
Table 43: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......48
Table 44: Oncology Drug Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......49
Table 45: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......50
Table 46: Oncology Market by Category in China (2015)-Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......51
Table 47: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......52
Table 48: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......53
Table 49: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......54
Diabetes Drugs......55
Table 50: Antidiabetes Molecules Market by Drug Worldwide (2015)-Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......55
Table 51: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......56
Table 52: Anti-Diabetic Drugs Market by Category in China (2015)-Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......57
Table 53: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......58
Table 54: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......59
Table 55: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......60
Table 56: Diabetes Market by Segment in the US (2015)-Percentage Share Breakdown by Value for Anti-Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Pres cription Medication and Others......61
Table 57: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......62
Table 58: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type 1 Diabetes, Insulin Type 2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP 1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......63
Table 59: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......64
Table 60: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......65
Table 61: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015)-Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......66
Table 62: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......67
Insulin......68
Table 63: Insulin Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog) and Rh Insulin......68
Table 64: Insulin Market by Generation in China (2014) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......69
Table 65: Insulin Market by Product Type in the US (2015)-Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......70
Table 66: Insulin Market by Type Worldwide (2015)-Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......71
Table 67: Insulin Market by Type Worldwide (2015)-Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......72
Respiratory......73
Table 68: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......73
Table 69: Respiratory Therapeutic Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......74
Pharmaceuticals......75
Table 70: Leading Pharmaceuticals Suppliers to Germany by Region Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Belgium, France, Great Britain, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, USA, and Others......75
Table 71: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......76
Table 72: Market Shares of Leading Pharmaceutical Companies in Australia (2015)-Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......77
Table 73: Market Shares of Leading Pharmaceutical Companies in India (2014) - Percentage Breakdown by Value for Abbott India Limited, Alembic Pharmaceuticals Limited, Alkem Laboratories, Aristo Pharmaceuticals Pvt Ltd., Cadila Pharmaceuticals Limited., Cipla Global Limited, Dr. Reddy's Laboratories., Emcure Pharmaceuticals Ltd., FDC Limited., GlaxoSmithKline Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Intas Pharmaceuticals limited, Lupin Limited, Macleods Pharmaceuticals Ltd., Mankind Pharma, Micro Labs Ltd., Novartis AG, Pfizer Limited, India., Ranbaxy Laboratories Limited, Sanofi India Limited, Sun India Pharmacy (P) Ltd., Torrent Pharmaceuticals Limited., Unichem Laboratories, USV Limited., Wockhardt Ltd., and Others......78
Cancer Drugs......79
Table 74: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......79
Table 75: Market Shares of Leading Oncology Drug Manufacturers in China (2015)-Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......80
Table 76: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......81
Table 77: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......82
Diabetes Drugs......83
Table 78: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......83
Table 79: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......84
Table 80: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......85
Central Nervous System (CNS) Medicine......86
Table 81: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Torrent Pharmaceuticals Ltd, and Others......86
Table 82: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......87
Respiratory Therapeutic......88
Table 83: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......88
Insulin......89
Table 84: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co, Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......89
Table 85: Market Shares of Leading Insulin Companies in China (2015)-Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......90
Table 86: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......91
Table 87: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......92
Table 88: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S and Others......93
Table 89: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......94
Table 90: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A. and Others......95
Table 91: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Cadila Pharmaceuticals Limited, Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Limited, Pfizer India Limited, Ranbaxy Laboratories Limited, Sanofi India Limited, Shreya Life Sciences Pvt. Ltd, USV Limited and Wockhardt Ltd.......96
Table 92: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015)-Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......97
Table 93: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co, Ltd.......98
Table 94: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......99
Table 95: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......100
Table 96: Takeda Pharmaceutical Co., Ltd.'s Sales by Segment Worldwide (2015) - Percentage Market Share Breakdown by Value for Consumer, Japan Pharma, Overseas Pharma, and Others......101
Table 97: Takeda Pharmaceutical Co., Ltd.'s Sales by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for Central Nervous System, Cardiovascular (CV) and Metabolic, General Medicine, Other, and Oncology......102
Table 98: Takeda Pharmaceutical Co., Ltd.'s Sales by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Asia, Domestic, Europe, Latin America, US, and Others......103
Table 99: Takeda Pharmaceutical Co., Ltd.'s Sales by Geographic Region Worldwide (2013) in Percentage for Japan, Americas, Europe, Asia and Others......104
Table 100: Takeda Pharmaceutical Co., Ltd.'s Sales by Product Segment Worldwide (2012-2013) in ¥ Millions for Ethical Drug, Consumer Healthcare and Others......105